A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. The study by lead author Justin Balko, Pharm.D., Ph.D., was published online June 10, 2012 […]
News: justin balko
Justin Balko, Pharm.D., Ph.D., was named Vanderbilt-Ingram Cancer Center’s Postdoctoral Fellow of the Year. He describes some of his breast cancer research pertaining to drug resistance and targeted therapeutics. He also notes the exceptional translational research environment that Vanderbilt provides. Balko is a researcher in the Carlos Arteaga lab.
Subscribe to our e-Newsletter to receive email updates: